
Saturday, January 21, 2023 10:40:05 PM
A Chief of Staff does not make policy, but he (or she) does help the President and his senior leadership achieve a consensus on what the most important policies to pursue are, and then how to implement them effectively. What’s wrong with Fannie and Freddie now is that they are on Treasury and FHFA “institutional auto-pilot,” heading in a non-sensical direction that is doing great harm to a key constituency of the Democratic party, low- and moderate-income homebuyers. As I’ve been saying for some time, to fix that will require some senior member of the Biden economic team to step up and make thoughtful secondary mortgage market reform a high personal priority. I wasn’t thinking that Ron Klain would be that person, but he certainly could have been a big help in making a change in policy toward Fannie and Freddie successful. As a former senior advisor to Fannie’s Office of the Chairman (of which I was a member for the last five years I was there), Klain knew the company and its business in a way that very few in government do. And of course he had great credibility and clout among Biden’s senior economic policy team, and with the President himself. We’ll have to see who Biden picks as his next COS (of the names I’ve heard bruited about, the only one I know to have some familiarity with Fannie and Freddie is Steve Ricchetti), but in my view not having Klain in that role will make getting the companies out of conservatorship in the next two years a tougher lift than it already was shaping up to be."

Liked By
Spread the love. Be the first to like this post!
Recent FNMA News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/14/2023 12:27:31 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:31:58 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:31:28 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:22:27 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:21:06 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:17:16 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:01:39 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:59:22 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:56:03 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:49:15 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:39:16 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:32:23 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:30:30 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:23:43 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:15:26 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:09:21 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:54:56 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:48:45 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:44:05 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:34:01 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:33:23 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:27:05 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:13:11 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:11:51 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:04:46 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM